
|Videos|November 16, 2020
AAO 2020: Study outlines use of injectable intraocular steroid over drops
Author(s)OT Staff Reports
Robert Weinstock, MD, presents data from a retrospective multicenter study focusing on the efficacy of dexamethasone intraocular suspension 9% delivered at the time of cataract surgery.
Advertisement
Robert Weinstock, MD, director of Cataract & Refractive Surgery, The Eye Institute of West Florida; the Weinstock Laser Eye Center, presents real-world data from a retrospective multicenter study focusing on the efficacy of dexamethasone intraocular suspension 9% delivered at the time of cataract surgery.
Weinstock notes that research shows the injections can decrease inflammation and control IOP.
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
First patient dosed in phase I/II trial of complement-targeting gene therapy for geographic atrophy
2
OLN324 shows comparable vision gains, potential durability advantage vs faricimab in phase 1b wAMD, DME study
3
Merck launches phase 2b/3 MALBEC trial of MK-8748 in wet AMD
4
FDA approves extended dosing intervals up to 20 weeks for EYLEA HD in wAMD and DME
5


























